Gene therapy advancements to treat Cockayne syndrome

Researchers working with UMass Chan Medical School’s Translational Institute for Molecular Therapeutics announced progress in developing a vector to deliver gene replacement therapy in mice models with Cockayne syndrome, a rare, fatal neurodegenerative disease that largely affects children and young adults.
bit.ly/3WIbNDu